Cargando…

Delineation of the Prostate Bed: The “Invisible Target” Is Still an Issue?

For pathological high-risk prostate cancer, adjuvant irradiation has shown a survival benefit. Phase III studies have highlighted that half men would face biochemical relapse and would be candidate for radiotherapy at adjuvant or salvage times. Despite at least four published international contourin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Latorzeff, Igor, Sargos, Paul, Loos, Geneviève, Supiot, Stéphane, Guerif, Stéphane, Carrie, Christian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5449739/ https://www.ncbi.nlm.nih.gov/pubmed/28620579 http://dx.doi.org/10.3389/fonc.2017.00108

Ejemplares similares

Post-Prostatectomy Image-Guided Radiotherapy: The Invisible Target Concept
por: Vilotte, Florent, et al.
Publicado: (2017)

Drug Intensification in Future Postoperative Radiotherapy Practice in Biochemically-Relapsing Prostate Cancer Patients
por: Cailleteau, Axel, et al.
Publicado: (2021)

Post-Operative Radiotherapy in Prostate Cancer: Is It Time for a Belt and Braces Approach?
por: Giraud, Nicolas, et al.
Publicado: (2021)

Late Gastrointestinal Tolerance After Prostate Radiotherapy: Is the Anal Canal the Culprit? A Narrative Critical Review
por: Sargos, Paul, et al.
Publicado: (2021)

Editorial: Post Operative Radiation Treatment for Prostate Cancer
por: Latorzeff, I., et al.
Publicado: (2022)

PET/CT-Based Salvage Radiotherapy for Recurrent Prostate Cancer After Radical Prostatectomy: Impact on Treatment Management and Future Directions
por: le Guevelou, Jennifer, et al.
Publicado: (2021)

Cost and Toxicity Comparisons of Two IMRT Techniques for Prostate Cancer: A Micro-Costing Study and Weighted Propensity Score Analysis Based on a Prospective Study
por: Masson, Ingrid, et al.
Publicado: (2022)

Editorial: Controversies and Perspectives in the Use of Postoperative Radiotherapy for Prostate Cancer
por: Dal Pra, Alan, et al.
Publicado: (2017)

Mechanistic Insights into Molecular Targeting and Combined Modality Therapy for Aggressive, Localized Prostate Cancer
por: Dal Pra, Alan, et al.
Publicado: (2016)

ESTRO ACROP guideline on prostate bed delineation for postoperative radiotherapy in prostate cancer
por: Dal Pra, Alan, et al.
Publicado: (2023)

Interaction Between Modern Radiotherapy and Immunotherapy for Metastatic Prostate Cancer
por: Ollivier, Luc, et al.
Publicado: (2021)

Preclinical Evaluation of Intraoperative Low-Energy Photon Radiotherapy Using Spherical Applicators in Locally Advanced Prostate Cancer
por: Buge, François, et al.
Publicado: (2015)

Targeting Local Recurrence After Surgery With MRI Imaging for Prostate Cancer in the Setting of Salvage Radiation Therapy
por: Renard-Penna, Raphaële, et al.
Publicado: (2022)

Oligometastatic prostate cancer: is it worth targeting the tip of the iceberg?
por: Supiot, Stéphane, et al.
Publicado: (2019)

Mapping of Recurrence Sites Following Adjuvant or Salvage Radiotherapy for Prostate Cancer Patients
por: Gonzalez-Moya, Ana, et al.
Publicado: (2022)

The application of multiple metrics in deformable image registration for target volume delineation of breast tumor bed
por: Xie, Xin, et al.
Publicado: (2022)

Comparison of Automated Atlas-Based Segmentation Software for Postoperative Prostate Cancer Radiotherapy
por: Delpon, Grégory, et al.
Publicado: (2016)

Intensity-modulated radiotherapy for prostate cancer with seminal vesicle involvement (T3b): A multicentric retrospective analysis
por: Goupy, Flora, et al.
Publicado: (2019)

Combined abiraterone acetate plus prednisone, salvage prostate bed radiotherapy and LH-RH agonists (CARLHA-GEP12) in biochemically-relapsing prostate cancer patients following prostatectomy: A phase I study of the GETUG/GEP
por: Supiot, Stéphane, et al.
Publicado: (2018)

Integrating Geriatric Assessment into Decision-Making after Prostatectomy: Adjuvant Radiotherapy, Salvage Radiotherapy, or None?
por: Goineau, Aurore, et al.
Publicado: (2015)

Use of a Biodegradable, Contrast-Filled Rectal Spacer Balloon in Intensity-Modulated Radiotherapy for Intermediate-Risk Prostate Cancer Patients: Dosimetric Gains in the BioPro-RCMI-1505 Study
por: Latorzeff, Igor, et al.
Publicado: (2021)

Radiomics for detecting prostate cancer bone metastases invisible in CT: a proof-of-concept study
por: Hinzpeter, Ricarda, et al.
Publicado: (2021)

Still in the closet: the invisible minority in medical education
por: Lapinski, Jessica, et al.
Publicado: (2014)

Challenges for Quality Assurance of Target Volume Delineation in Clinical Trials
por: Chang, Amy Tien Yee, et al.
Publicado: (2017)

Deep learning‐based classification and structure name standardization for organ at risk and target delineations in prostate cancer radiotherapy
por: Jamtheim Gustafsson, Christian, et al.
Publicado: (2021)

CT-pathologic correlation in primary hepatocellular carcinoma: an implication for target delineation
por: Chen, Hai-yan, et al.
Publicado: (2013)

Stereotactic Re-irradiation for Local Recurrence in the Prostatic Bed After Prostatectomy: Preliminary Results
por: Olivier, Jonathan, et al.
Publicado: (2019)

Evaluation of tumor hypoxia prior to radiotherapy in intermediate-risk prostate cancer using (18)F-fluoromisonidazole PET/CT: a pilot study
por: Supiot, Stéphane, et al.
Publicado: (2018)

Randomized phase II trial in prostate cancer with hormone-sensitive OligometaSTatic relapse: Combining stereotactic ablative radiotherapy and durvalumab (POSTCARD GETUG P13): Study protocol
por: Rogé, Maximilien, et al.
Publicado: (2023)

Delineation of Radiation Therapy Target Volumes for Lingual Nerve Involvement
por: Sozio, Stephen J, et al.
Publicado: (2022)

Feasibility of Different Tumor Delineation Approaches for (18)F-PSMA-1007 PET/CT Imaging in Prostate Cancer Patients
por: Mittlmeier, Lena M., et al.
Publicado: (2021)

The Definition and Delineation of the Target Area of Radiotherapy Based on the Recurrence Pattern of Glioblastoma After Temozolomide Chemoradiotherapy
por: Zheng, Lin, et al.
Publicado: (2021)

The Many Faces of Neuroendocrine Differentiation in Prostate Cancer Progression
por: Terry, Stéphane, et al.
Publicado: (2014)

Advances in the intraoperative delineation of malignant glioma margin
por: Jiang, Shan, et al.
Publicado: (2023)

Target volume delineation for radiotherapy of meningiomas: an ANOCEF consensus guideline
por: Martz, Nicolas, et al.
Publicado: (2023)

Sentinel Lymph Node Biopsy: A Great Opportunity for Personalized Radiotherapy in Prostate Cancer
por: Supiot, Stéphane, et al.
Publicado: (2023)

Variations of Clinical Target Volume Delineation for Primary Site of Nasopharyngeal Cancer Among Five Centers in China
por: Zhang, Shichuan, et al.
Publicado: (2020)

A new approach to delineating clinical target volume for radiotherapy of glioblastoma: A phase II trial
por: Huang, Yong, et al.
Publicado: (2022)

Impact of fiducial markers placement on the delineation of target volumes in radiation therapy for oesophageal cancer: FIDUCOR study
por: Rochigneux, Philippe, et al.
Publicado: (2022)

Still ignored and still invisible: the situation of displaced people and people affected by disasters in the COVID-19 pandemic
por: Abeldaño Zuñiga, Roberto Ariel, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_o3147hkski7go6idguknhbn8av